LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release

Autores
Cussa, Jorgelina; Juárez, Juliana María; Gómez Costa, Marcos Bruno; Anunziata, Oscar Alfredo
Año de publicación
2022
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response.
Fil: Cussa, Jorgelina. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Fil: Juárez, Juliana M.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Fil: Gómez Costa, Marcos B.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Fil: Anunziata, Oscar A.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Peer Reviewed
Materia
LP-SBA-15
ketorolac tromethamine
nanostructured host
drug-delivering device
nanoscale medicine.
Nivel de accesibilidad
acceso abierto
Condiciones de uso
2024-04-18T22:55:45Z
Repositorio
Repositorio Institucional Abierto (UTN)
Institución
Universidad Tecnológica Nacional
OAI Identificador
oai:ria.utn.edu.ar:20.500.12272/10597

id RIAUTN_c9fdfd2b337021e55eaf93db8d72e4eb
oai_identifier_str oai:ria.utn.edu.ar:20.500.12272/10597
network_acronym_str RIAUTN
repository_id_str a
network_name_str Repositorio Institucional Abierto (UTN)
spelling LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto releaseCussa, JorgelinaJuárez, Juliana MaríaGómez Costa, Marcos BrunoAnunziata, Oscar AlfredoLP-SBA-15ketorolac tromethaminenanostructured hostdrug-delivering devicenanoscale medicine.Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response.Fil: Cussa, Jorgelina. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.Fil: Juárez, Juliana M.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.Fil: Gómez Costa, Marcos B.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.Fil: Anunziata, Oscar A.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.Peer Reviewed2024-04-18T22:55:45Z2024-04-18T22:55:45Z2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articulopdfapplication/pdfhttp://hdl.handle.net/20.500.12272/10597-enginfo:eu-repo/semantics/openAccess2024-04-18T22:55:45Zhttp://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 InternacionalJuárez, Juliana M.https://creativecommons.org/licenses/by-nc-sa/4.0/reponame:Repositorio Institucional Abierto (UTN)instname:Universidad Tecnológica Nacional2026-09-24T12:48:39Zoai:ria.utn.edu.ar:20.500.12272/10597instacron:UTNInstitucionalhttp://ria.utn.edu.ar/Universidad públicaNo correspondehttp://ria.utn.edu.ar/oaigestionria@rec.utn.edu.ar; fsuarez@rec.utn.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2026-09-24 12:48:40.076Repositorio Institucional Abierto (UTN) - Universidad Tecnológica Nacionalfalse
dc.title.none.fl_str_mv LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
title LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
spellingShingle LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
Cussa, Jorgelina
LP-SBA-15
ketorolac tromethamine
nanostructured host
drug-delivering device
nanoscale medicine.
title_short LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
title_full LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
title_fullStr LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
title_full_unstemmed LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
title_sort LP-SBA-15/ketorolac nanocomposite: development, characterization, and mathematical modeling of controlled keto release
dc.creator.none.fl_str_mv Cussa, Jorgelina
Juárez, Juliana María
Gómez Costa, Marcos Bruno
Anunziata, Oscar Alfredo
author Cussa, Jorgelina
author_facet Cussa, Jorgelina
Juárez, Juliana María
Gómez Costa, Marcos Bruno
Anunziata, Oscar Alfredo
author_role author
author2 Juárez, Juliana María
Gómez Costa, Marcos Bruno
Anunziata, Oscar Alfredo
author2_role author
author
author
dc.subject.none.fl_str_mv LP-SBA-15
ketorolac tromethamine
nanostructured host
drug-delivering device
nanoscale medicine.
topic LP-SBA-15
ketorolac tromethamine
nanostructured host
drug-delivering device
nanoscale medicine.
dc.description.none.fl_txt_mv Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response.
Fil: Cussa, Jorgelina. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Fil: Juárez, Juliana M.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Fil: Gómez Costa, Marcos B.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Fil: Anunziata, Oscar A.. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación en Nanociencia y Nanotecnología. Córdoba; Argentina.
Peer Reviewed
description Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response.
publishDate 2022
dc.date.none.fl_str_mv 2022
2024-04-18T22:55:45Z
2024-04-18T22:55:45Z
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12272/10597
-
url http://hdl.handle.net/20.500.12272/10597
identifier_str_mv -
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
2024-04-18T22:55:45Z
http://creativecommons.org/licenses/by-nc-nd/4.0/
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Juárez, Juliana M.
https://creativecommons.org/licenses/by-nc-sa/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv 2024-04-18T22:55:45Z
http://creativecommons.org/licenses/by-nc-nd/4.0/
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Juárez, Juliana M.
https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.format.none.fl_str_mv pdf
application/pdf
dc.source.none.fl_str_mv reponame:Repositorio Institucional Abierto (UTN)
instname:Universidad Tecnológica Nacional
reponame_str Repositorio Institucional Abierto (UTN)
collection Repositorio Institucional Abierto (UTN)
instname_str Universidad Tecnológica Nacional
repository.name.fl_str_mv Repositorio Institucional Abierto (UTN) - Universidad Tecnológica Nacional
repository.mail.fl_str_mv gestionria@rec.utn.edu.ar; fsuarez@rec.utn.edu.ar
_version_ 1877230970221887488
score 13.24418